Pushpendra Singh
Senior Director, Head of Product Development Ocugen
Results-driven drug development leader with expertise spanning discovery through regulatory approval. Specialized in CMC and preclinical strategy with strong regulatory intelligence (pre-IND, IND, BLA, orphan drug applications, briefing packages). Broad experience across cell and gene therapies, biologics, and vaccines, with successful leadership of programs in ophthalmology, infectious disease, orthopedics, and neurological disorders. Recognized for building effective global collaborations with CDMOs, CROs, and academic partners, and passionate about advancing transformative therapies to improve patient outcomes.
Seminars
Wednesday 25th March 2026
Revolutionizing Manufacturing to Make Gene Therapies Affordable
1:30 pm
- Forecasting next-generation technologies that could dramatically reduce production costs
- Pinpointing remaining scientific and technical barriers to scalable manufacturing
- Aligning innovation timelines with clinical and commercial readiness to support faster adoption
